Drug
Petosemtamab Pembrolizumab
Petosemtamab Pembrolizumab: highest development phase Phase 2, developed by Merus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Merus
Trials
| Drug | Phase | Indication |
|---|---|---|
| Petosemtamab + Pembrolizumab NCT07353957 | Phase 2 | Lung Cancer - Non Small Cell Squamous |
Latest
No recent events.
Follow Petosemtamab Pembrolizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.